Contract 36C25726N0241
Exelan Pharmaceuticals Inc · Department Of Veterans Affairs · February 5, 2026
Exelan Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on February 5, 2026 for $899,000 of work in pharmaceutical preparation manufacturing. Performance is in Boca Raton, FL. This is a task or delivery order issued under parent IDIQ 36F79720D0227. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 27, 2026.
Contract details
- PIID
- 36C25726N0241
- Parent IDIQ
- 36F79720D0227
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Family & Internal Medicine Services
- Place of performance
- Boca Raton, FL
- First action
- February 5, 2026
- Latest action
- March 27, 2026
Description
PERIOD OF PERFROMANCE EXTENDED-LENALIDOMIDE ORAL MED
Modification timeline
-
March 27, 2026Mod P00001$0
-
February 5, 2026Base awardLENALIDOMIDE ORAL MED$899.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C25726N0241?
Contract 36C25726N0241 is a federal contract awarded to Exelan Pharmaceuticals Inc by Department Of Veterans Affairs on February 5, 2026 for $899,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36C25726N0241?
Exelan Pharmaceuticals Inc won contract 36C25726N0241 from Department Of Veterans Affairs.
How much is contract 36C25726N0241 worth?
Contract 36C25726N0241 has obligated $899,000 to date.